VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 13, 2014) - BioAB Strategies Ltd. (the "Company") is pleased to announce that it has closed its previously announced non-brokered financing (the "Financing") and has issued a total of 5,000,000 units (the "Units") for aggregate proceeds of $200,000, at a price of $0.04 per Unit. Each Unit is comprised of one common share and one share purchase warrants, exercisable to purchase one common share for one year at a price of $0.06.